ENOB Projected Dividend Yield
Enochian Biosciences Inc ( NASDAQ : ENOB )Enochian BioSciences is a pre-clinical stage biotechnology company. Co.'s product candidates include: ENOB-HV-01 for autologous Human Immunodeficiency Virus (HIV) curative treatment; ENOB-HV-11 for preventive HIV vaccine; ENOB-HV-12 for therapeutic HIV vaccine; ENOB-HV-21 for HIV natural killer and gamma delta T-cell treatment or cure; ENOB-HV-31 for in vivo gene therapy; ENOB-HB-01 for hijacking Hepatitis B Virus polymerase; ENOB-CV-01 for coronavirus treatment; ENOB-CV-11 for coronavirus prophylaxis; ENOB-FL-01 for influenza treatment; ENOB-FL-11 for influenza prophylaxis; and ENOB-DC-11 for off the shelf dendritic cell vaccine for multiple solid tumors. 20 YEAR PERFORMANCE RESULTS |
ENOB Dividend History Detail ENOB Dividend News ENOB Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |